{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Leukemia, Prostate and Renal Cancer Treatment Updates
Activity Steps
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Purpose of Activity
To present the latest treatment information for various leukemias, renal cell and prostate cancer.Learning Objectives
After completing this continuing education activity you will be able to:
- List the latest treatments for several types of leukemia.
- Outline current strategies for treating renal cell and prostate cancers.
Disclosures
The authors and planners have no conflicts of interest to disclose.
Price:
$24.95
Credits:
- ANCC 2.9 CH
- DC - BON 2.9 CH
- KY-BON 2.5 CH
Lippincott Williams & Wilkins is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.--------------------------------------------------This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Williams & Wilkins is also an approved provider of continuing nursing education by the District of Columbia and Florida #50-1223. Your certificate is valid in all states.--------------------------------------------------The ANCC's accreditation status of Lippincott Williams & Wilkins Department of Continuing Education refers only to its continuing nursing educational activities and does not imply Commission on Accreditation approval or endorsement of any commercial product.
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Test Code: OT0113
Published: January 25, 2013
Expires: 12/31/2026
Sources:
Oncology Times
Required Passing Score: 12/16 (75%)
Specialties:
Oncology